Accolade, Inc. ( ACCD ) NASDAQ Global Select

Cena: 7.02 ( 0.0% )

Aktualizacja 04-08 22:00
NASDAQ Global Select
Branża: Medical - Healthcare Information Services

Notowania:
An error occurred: DataFrame is empty. Check the ticker or date range.


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 2 400
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 89%
Ilość akcji: 77 407 600
Debiut giełdowy: 2020-07-01
WWW: https://www.accolade.com
CEO: Mr. Rajeev Singh
Adres: 660 West Germantown Pike
Siedziba: 19462 Plymouth Meeting
ISIN: US00437E1029
Opis firmy:

Accolade, Inc., wraz ze swoimi spółkami zależnymi, rozwija i zapewnia rozwiązania obsługujące technologię, które pomagają ludziom zrozumieć, nawigować i wykorzystywać system opieki zdrowotnej i ich korzyści w miejscu pracy w Stanach Zjednoczonych. Firma oferuje platformę z technologią w chmurze i multimodalnym wsparciem zespołu asystentów i klinicystów zdrowotnych, w tym pielęgniarek, dyrektorów medycznych lekarzy i specjalistów ds. Zdrowia behawioralnego. Zapewnia również usługi konsultacji drugiej opinii i usług wsparcia decyzji o opiece zdrowotnej. Firma obsługuje pracodawców, którzy zapewniają rodzinom pracownikom i swoim pracownikom jedno miejsce, w którym można zwrócić się do ich potrzeb zdrowotnych, zdrowotnych i świadczeń. Accolade, Inc. została zarejestrowana w 2007 r. I ma siedzibę na spotkaniu Plymouth w Pensylwanii.

Wskaźniki finansowe
Kapitalizacja (USD) 575 591 590
Aktywa: 756 072 000
Cena: 7.02
Wskaźnik Altman Z-Score: -1.1
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -3.1
Ilość akcji w obrocie: 89%
Średni wolumen: 1 565 611
Ilość akcji 81 993 104
Wskaźniki finansowe
Przychody TTM 441 028 000
Zobowiązania: 332 998 000
Przedział 52 tyg.: 3.08 - 9.67
Piotroski F-Score: 5
Umiarkowany (średnia jakość finansowa)
EPS: -2.3
P/E branży: 32.4
Beta: 2.016
Raport okresowy: 2025-04-23
WWW: https://www.accolade.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Rajeev Singh Chairman of the Board & Chief Executive Officer 503 500 1968
Mr. Robert Cavanaugh President 413 500 1969
Mr. Stephen H. Barnes CPA Chief Financial Officer & Treasurer 403 500 1971
Mr. Richard Eskew Executive Vice President, General Counsel, CCO & Secretary 353 500 1976
Ms. Kelsi McDonald Harris Chief People Officer & Senior Vice President 0 0
Mr. Colin McHugh Chief Accounting Officer 0 1979
Ms. Kristen Bruzek Senior Vice President of Operations 0 0
Mr. Todd Friedman Senior Vice President of Investor Relations 0 0
Dr. Shantanu Nundy M.B.A., M.D. Executive Vice President, Chief Health Officer & Member of the Medical Advisory Board 0 0
Mr. Drew Garner Executive Vice President of Engineering 0 0
Wiadomości dla Accolade, Inc.
Tytuł Treść Źródło Aktualizacja Link
Accolade to Announce Fiscal Third Quarter 2025 Financial Results SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. globenewswire.com 2024-12-16 10:00:00 Czytaj oryginał (ang.)
Accolade: A GARP Stock Trading Well Under 1X Revenues Accolade, Inc. is a promising buy due to tax loss season, with potential for a January recovery and long-term growth prospects. The stock's significant drop is attributed to IPO fallout and an overreaction to a minor revenue guidance decline. Its stock trades at a significant discount to its peers despite growing faster than all but one. seekingalpha.com 2024-12-05 07:05:04 Czytaj oryginał (ang.)
Accolade (ACCD) Upgraded to Buy: Here's Why Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). zacks.com 2024-12-03 15:06:21 Czytaj oryginał (ang.)
Accolade To Present at Upcoming Investor Conferences SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. globenewswire.com 2024-11-13 10:00:00 Czytaj oryginał (ang.)
Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating TORONTO--(BUSINESS WIRE)--Porter Airlines has been rated a 2025 Four Star Major Airline by passengers, certified by the Airline Passenger Experience Association (APEX). The APEX Five Star and Four Star Airlines Awards are the only global awards based entirely on neutral, third-party passenger feedback. They are a result of passenger ratings of almost one million flights across nearly 600 airlines around the world, certified by APEX in partnership with TripIt® from Concur®. “Receiving this ratin. businesswire.com 2024-10-31 11:03:00 Czytaj oryginał (ang.)
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Accolade (ACCD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com 2024-10-24 14:36:10 Czytaj oryginał (ang.)
Accolade Welcomes Renalogic to Trusted Partner Ecosystem Partnership will drive cost savings for customers while providing high-touch services that improve health outcomes to members with chronic kidney disease (CKD).  SEATTLE , Oct. 15, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Renalogic, the recognized industry leader that manages the human and financial costs of chronic kidney disease (CKD) for self-insured employers and their members, will join the company's Trusted Partner Ecosystem, to offer its proven CKD risk management and dialysis cost containment solutions. prnewswire.com 2024-10-15 13:00:00 Czytaj oryginał (ang.)
Accolade (ACCD) Upgraded to Buy: Here's What You Should Know Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). zacks.com 2024-10-10 17:00:25 Czytaj oryginał (ang.)
Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript Accolade, Inc. (NASDAQ:ACCD ) Q2 2025 Earnings Conference Call October 8, 2024 8:00 AM ET Company Participants Todd Friedman - Senior Vice President of Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Conference Call Participants Dan Clark - Leerink Partners Craig Hettenbach - Morgan Stanley Jailendra Singh - Truist Securities Jeff Garro - Stephens Inc. Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Jared Haase - William Blair Stephanie Davis - Barclays Allen Lutz - Bank of America Ryan MacDonald - Needham & Company Stan Berenshteyn - Wells Fargo David Larsen - BTIG Jack Wallace - Guggenheim Operator Ladies and gentlemen, thank you for standing by. Welcome to Accolade Second Quarter 2025 Earnings Results Conference Call. seekingalpha.com 2024-10-08 14:27:05 Czytaj oryginał (ang.)
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates Accolade (ACCD) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.43 per share a year ago. zacks.com 2024-10-08 13:10:24 Czytaj oryginał (ang.)
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30 On October 8, 2024, Accolade Inc (ACCD, Financial) released its 8-K filing detailing the financial results for the fiscal second quarter ending August 31, 2024. Accolade Inc, a company offering technology-enabled solutions to navigate the healthcare system, reported a revenue of $106.4 million, exceeding the analyst estimate of $105.01 million. gurufocus.com 2024-10-08 12:31:42 Czytaj oryginał (ang.)
Accolade Announces Results for Fiscal Second Quarter 2025 SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. globenewswire.com 2024-10-08 11:00:00 Czytaj oryginał (ang.)
Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings Accolade Inc (ACCD, Financial) is set to release its Q2 2025 earnings on Oct 8, 2024. The consensus estimate for Q2 2025 revenue is $105.01 million, and the earnings are expected to come in at -$0.44 per share. gurufocus.com 2024-10-07 12:01:45 Czytaj oryginał (ang.)
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings Accolade, Inc. ACCD will release earnings results for its second quarter, before the opening bell on Tuesday, Oct. 8. benzinga.com 2024-10-04 08:19:34 Czytaj oryginał (ang.)
Accolade to Announce Fiscal Second Quarter 2025 Financial Results SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction, the company will host a conference call to review results at 8:00 a.m. E.T. on the same day. globenewswire.com 2024-09-18 12:00:00 Czytaj oryginał (ang.)
Tri Pointe Homes Receives 2024 People Companies That Care® Accolade and 2024 Fortune Best Workplaces in Construction™ Distinction The competitive and prestigious awards recognize Tri Pointe Homes for its outstanding commitment to employee well-being and innovative workplace practices year-over-year The competitive and prestigious awards recognize Tri Pointe Homes for its outstanding commitment to employee well-being and innovative workplace practices year-over-year globenewswire.com 2024-09-10 16:00:00 Czytaj oryginał (ang.)
All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy Accolade (ACCD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2024-08-30 17:01:18 Czytaj oryginał (ang.)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share. accesswire.com 2024-08-29 11:25:00 Czytaj oryginał (ang.)
Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5 at 9:15 am ET. globenewswire.com 2024-08-28 12:00:00 Czytaj oryginał (ang.)
Accolade, Inc. (ACCD) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share. accesswire.com 2024-08-28 11:25:00 Czytaj oryginał (ang.)